What is AbCellera Biologics Inc (ABCL)?
AbCellera Biologics Inc is a biotechnology company specializing in the discovery and development of therapeutic antibodies. The company utilizes a proprietary technology platform that combines microfluidics, machine learning, and high-throughput screening to identify antibodies from natural immune responses. AbCellera collaborates with pharmaceutical and biotechnology companies to accelerate the development of antibody-based therapies for various diseases. Its platform supports rapid identification and optimization of antibody candidates, aiming to enhance drug discovery efficiency. The company operates within the biopharmaceutical sector, contributing to the advancement of biologic medicines.
AbCellera Biologics Inc Stock Price Today: Live Overview
The price today is shaped by ongoing market activity, AbCellera Biologics Inc is currently at $3.43. It has traded between $3.37 and $3.56, with a daily percentage change of -3.1429%.
FAQ: AbCellera Biologics Inc (ABCL)
What is the current price of ABCL stock?
AbCellera Biologics Inc is currently trading at $3.43.
Does ABCL pay dividends?
AbCellera Biologics Inc does not pay dividends.
Does ABCL have a formal corporate presence or regional headquarters in the UAE?
AbCellera Biologics Inc operates in the UAE through partners and distributors without an official regional office or subsidiary.
What is ABCL best known for?
AbCellera Biologics Inc is most famous for its antibody discovery platform.
What assets are typically shown together with ABCL?
Commonly shown alongside ABCL: Axon Enterprise Inc, uniQure N.V., Alnylam
Latest shares articles



